NMRA neumoratx.com Company Profit

NMRA (Neumora Therapeutics, Inc.) - company brandmark

Neumora Therapeutics focuses on developing innovative therapies for brain pathologies, with a profit metric of -0.21. This price trend chart confirms the business development dynamics. The company is supported by a staff of leading neuroscience experts attracted by large-scale investments. The production of pilot drug series is outsourced to external contractors, ensuring maximum efficiency of production cycles without technical pauses.

Net Income: Neumora Therapeutics Inc (NMRA) for 02/21/2024 - 11/01/2026

Analytical breakdowns and data insights for company Neumora Therapeutics, Inc. (NMRA)

- stock value and consensus price forecast:
Market Price Neumora Corp|NMRA - Price Target Chart
- market capitalization data:
Market Capitalization Neumora Corp|NMRA - Enterprise Value
- book capitalization information:
Net Asset Value per Share Neumora Therapeutics|NMRA - Company Net Assets|Market Capitalization to Book Value Ratio neumoratx.com|NMRA - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Neumora Therapeutics|NMRA - Long-Term Debt to Equity|Current Liabilities to Capital Neumora|NMRA - Company Debts|Debt to Net Assets Ratio Neumora Corp|NMRA - Company Long-Term Debts|Company Short-Term Debts Neumora Therapeutics|Intermediate Coverage Ratio neumoratx.com
- company profitability and valuation multiples indicators:
NMRA - Net Income
Basic company analysis:Neumora Corp (NMRA)
Core merchandise of Neumora Therapeutics

A defensive portfolio requires strict control over the recovery rate of net income. This metric compares daily profit with current market capitalization to identify the pace of balance sheet recovery. For Neumora Therapeutics (NMRA), this calculation is critical, as profit depends directly on the success of clinical trials and regulatory approvals. It is essential for investors to distinguish between planned research expansion and a systemic decline. The profit dynamics of Neumora Therapeutics (NMRA) clearly confirm the effectiveness of this strategy.

Direct competitors

Company Net Income Biogen Idec (BIIB)|Company Net Income Neurocrine Biosciences|Company Profit RGC (regencellbioscience.com)|Net Profit AXSM|ACAD - Company Net Income|Xenon Pharmaceuticals Inc - Net Income|Net Profit Viking Therapeutics Corp VKTX|SUPN - Company Net Income|catalystpharma.com (CPRX) - Net Income|Denali Therapeutics Inc. (DNLI) - Company Net Income|Company Net Income Harmony Biosciences Inc (HRMY)|Company Net Income Biohaven Pharmaceutical|AMLX: Final Profit|Net Profit TRVI|Net Profit praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|PRTA: Net Income|Alector, Inc. - Profit After Payment of Taxes|ANNX: Net Profit|Omeros - Final Profit|NGNE (Neurogene) - Net Profit|Company Net Income AC Immune S.A. ACIU|Company Net Income Voyager Pharma (VYGR)|SCLX (Scilex Holding Company, Inc.) - Final Profit|Net Profit TVGN (Tevogen Bio Holdings)|Net Profit Alpha Cognition Inc ACOG|CGTX - Company Net Income|Profit After Tax IKT|SAVA: Net Profit|Company Net Income Assertio (ASRT)|Net Income COYA|Net Profit VistaGen Therapeutics Inc|Net Income OVID (Ovid Therapeutics Inc.)|Profit After Payment of Taxes ABOS|Net Profit CRVO (CervoMed Inc)|Net Financial Result Alterity Therapeutics Ltd. (ATHE)|Clene Nanomedicine - Net Profit|PepGen Inc. (PEPG) - Net Income|Jupiter Neurosciences Inc (JUNS) - Company Net Income|RLMD - Net Financial Result|Company Net Income Annovis Bio Corp|Company Profit GRCE (Grace Tx)|Company Net Income Firefly Neuroscience, Inc (AIFF)|Net Income anewmeds.com KLTO|Company Net Income NeuroSense Therapeutics Ltd. NRSN|Final Profit RVPH|MetaVia, Inc. - Net Profit|NRXS - Net Profit|heliusmedical.com (HSDT) - Company Net Income|Company Profit PASG|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Company Net Income Minerva Neurosciences Inc NERV|Net Income ATHA (Athira)|Net Profit Addex (ADXN)|Company Net Income Alzamend Neuro ALZN|Final Profit CYCN|PTIX - Company Net Income|Company Net Income Pasithea Therapeutics|cortigent.com (CRGT) - Company Net Income|Company Profit ATXI|BCLI (Brainstorm Cell) - Net Profit|Company Net Income caratherapeutics.com CARA|Net Income CHRO (Chromocell Therapeutics Corp.)|Net Profit eliemtx.com (ELYM)|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH - Net Income|MRNS - Company Net Income|Company Net Income nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Sage Therapeutics Inc. - Final Profit|SNPX (Neurotrope) - Net Profit|Net Profit Trevena Inc|Net Income VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Final Profit|Cerevel Therapeutics, Inc. - Net Income